ANGELA HILBRENNER: Open Payments
NPI 1871754564 · CLINTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 31 payments from 12 companies in 2025. Trend: 2023 $205 · 2024 $596 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $135 |
| Teva Pharmaceuticals USA, Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Novo Nordisk Inc | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| ABBVIE INC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| PFIZER INC. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: OTEZLA, AUSTEDO XR, CAPLYTA, Ozempic, Cologuard Collection Kit, REXULTI, UBRELVY, REPATHA.
Industry payments across MO — which companies pay providers there.
